Company Filing History:
Years Active: 1993-1999
Title: Larry T Mimms: Pioneering Innovations in Hepatitis Research
Introduction:
Larry T Mimms, a remarkable inventor based in Lake Villa, IL, has made significant contributions to the field of hepatitis research. With six patents to his name, Mimms has demonstrated his expertise in developing diagnostic and therapeutic solutions for Hepatitis B and Hepatitis C viruses. Currently affiliated with Abbott Laboratories Corporation, Mimms continues to push the boundaries of medical innovation.
Latest Patents:
Mimms's latest patents focus on the detection and treatment of Hepatitis B and Hepatitis C viruses. The first patent, titled "Hepatitis B virus mutants, reagents, and methods for detection," describes mutant Hepatitis B Virus (HBV) nucleic acid sequences that can be utilized in various diagnostic and therapeutic applications. This patent also covers kits for using these sequences, HBV immunogenic particles, and a method for producing antibodies to HBV.
The second patent, titled "Monoclonal antibodies to Hepatitis C virus and method for using same," highlights the development of monoclonal antibodies that specifically bind to different Hepatitis C Virus proteins: C-100, 33C, and CORE. These antibodies, along with the corresponding hybridomas that produce them, have diverse applications in the field. The patent also mentions the use of these monoclonal antibodies in various assays.
Career Highlights:
Throughout his career, Larry T Mimms has exhibited a deep commitment to advancing medical technologies. His patented inventions have contributed significantly to the diagnosis, treatment, and understanding of Hepatitis B and Hepatitis C viruses. These breakthroughs have the potential to improve patient outcomes and save lives.
Collaborations:
In his pursuit of innovation, Larry T Mimms has worked closely with his colleague, Richard H Decker. Their collaborative efforts have yielded groundbreaking solutions in the field of hepatitis research. Together, they have paved the way for improved diagnostic methods and therapeutic options for individuals affected by these viruses.
Conclusion:
Larry T Mimms's exceptional work at Abbott Laboratories Corporation showcases his profound contributions to the field of hepatitis research. Through his innovative patents, he has played a pivotal role in developing diagnostic tools, treatment methods, and therapeutic antibodies for Hepatitis B and Hepatitis C. Mimms's relentless dedication to medical innovation continues to inspire and benefit both patients and healthcare professionals worldwide.